To establish a permanent framework for negotiating prices of high-cost drugs, the Centers for Medicare & Medicaid Services (CMS) has finalized a rule.
The final rule sets policies for the Medicare Drug Price Negotiation Program beginning with prices effective in 2029. The Negotiation Program, created by the Inflation Reduction Act